Capital Market Strategies’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$524K Sell
965
-89
-8% -$46.5K 0.36% 51
2025
Q1
$522K Sell
1,054
-183
-15% -$101K 0.35% 55
2024
Q4
$646K Buy
1,237
+90
+8% +$46.9K 0.37% 55
2024
Q3
$563K Sell
1,147
-19
-2% -$8.85K 0.34% 57
2024
Q2
$519K Sell
1,166
-24
-2% -$9.56K 0.33% 58
2024
Q1
$475K Buy
1,190
+5
+0.4% +$1.89K 0.36% 65
2023
Q4
$400K Sell
1,185
-16
-1% -$4.77K 0.35% 70
2023
Q3
$346K Buy
1,201
+174
+17% +$54.3K 0.35% 75
2023
Q2
$351K Buy
+1,027
New +$311K 0.33% 78
2023
Q1
Sell
-1,108
Closed -$294K 84
2022
Q4
$294K Sell
1,108
-90
-8% -$21.9K 0.32% 89
2022
Q3
$225K Sell
1,198
-429
-26% -$92.1K 0.25% 107
2022
Q2
$327K Hold
1,627
0.34% 85
2022
Q1
$491K Buy
1,627
+973
+149% +$284K 0.42% 57
2021
Q4
$235K Buy
+654
New +$225K 0.19% 129

Other funds holding ISRG

Capital Market Strategies's ISRG Position: Q2 2025 in Review

Capital Market Strategies reduced its Intuitive Surgical (ISRG) stake by 8.4% in Q2 2025, selling an estimated $46.5K and leaving 965 shares worth $524K. The position accounts for 0.36% of the portfolio, ranked #51.

Capital Market Strategies first reported a position in ISRG in Q4 2021 and has held it in 14 quarters since. The position peaked at $646K in Q4 2024. 2,270 funds tracked by Wall St. Rank hold ISRG as of Q2 2025.

  • Capital Market Strategies held 965 shares of Intuitive Surgical worth $524K as of Q2 2025.
  • Capital Market Strategies sold 89 Intuitive Surgical shares in Q2 2025, an estimated $46.5K.
  • Intuitive Surgical made up 0.36% of Capital Market Strategies's portfolio in Q2 2025, its #51 holding.
  • Capital Market Strategies first reported a position in Intuitive Surgical in Q4 2021 and has held it in 14 quarters since.
  • Capital Market Strategies's Intuitive Surgical position peaked at $646K in Q4 2024.
  • 2,270 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2025.

Based on Capital Market Strategies's 13F filing for Q2 2025, filed 2 Jul 2025.